File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1210/jc.2006-1877
- Scopus: eid_2-s2.0-34249852339
- PMID: 17327384
- WOS: WOS:000246221200029
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Hemodynamic changes in hyperthyroidism-related pulmonary hypertension: A prospective echocardiographic study
Title | Hemodynamic changes in hyperthyroidism-related pulmonary hypertension: A prospective echocardiographic study |
---|---|
Authors | |
Issue Date | 2007 |
Publisher | The Endocrine Society. The Journal's web site is located at http://jcem.endojournals.org |
Citation | Journal Of Clinical Endocrinology And Metabolism, 2007, v. 92 n. 5, p. 1736-1742 How to Cite? |
Abstract | Context: Recent reports suggest an association between hyperthyroidism and pulmonary hypertension (PHT), although the potential mechanisms and clinical implications remain unclear. Objective: Our objective was to determine the prevalence of PHT related to hyperthyroidism and the associated hemodynamic changes and outcome. Methods and Results: We performed serial echocardiographic examinations in 75 consecutive patients with hyperthyroidism (43 ± 2 yr, 47 women) to estimate pulmonary artery systolic pressure (PASP), cardiac output (CO), total vascular resistance (TVR), and left ventricular (LV) filling pressure. Examinations were performed at baseline and 6 months after initiation of antithyroid treatment. Results were compared with 35 age- and sex-matched healthy controls. All hyperthyroid patients had normal LV systolic function, and 35 patients (47%) had PHT with PASP of at least 35 mm Hg. There were no significant differences in the clinical characteristics of hyperthyroid patients with or without PHT (all P > 0.05). Nonetheless, those with PHT had significantly higher CO, PASP, peak transmitral early diastolic flow velocity (E), and ratio of E to early diastolic mitral annular velocity (E′) compared with those without PHT and controls (all P < 0.05). Hyperthyroid patients with PHT also had significantly lower TVR than controls (P < 0.05). Among the 35 hyperthyroid patients with PHT, 25 (71%) had pulmonary arterial hypertension (PAH) with normal E/E′, and 10 (29%) had pulmonary venous hypertension (PVH) with elevated E/E′. Hyperthyroid patients with PAH had a significantly higher CO and a lower TVR compared with those with PVH. In contrast, hyperthyroid patients with PVH had lower E′ and a higher E/E′ ratio compared with those with PAH. These hemodynamic abnormalities and PHT were reversible in patients with PAH or PVH after restoration to a euthyroid state. Conclusion: In patients with hyperthyroidism and normal LV systolic function, up to 47% had PHT due to either PAH with increased CO (70%) or PVH with elevated LV filling pressure (30%). Most importantly, hyperthyroidism-related PHT was largely asymptomatic and reversible after restoration to a euthyroid state. Copyright © 2007 by The Endocrine Society. |
Persistent Identifier | http://hdl.handle.net/10722/76299 |
ISSN | 2023 Impact Factor: 5.0 2023 SCImago Journal Rankings: 1.899 |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Siu, CW | en_HK |
dc.contributor.author | Zhang, XH | en_HK |
dc.contributor.author | Yung, C | en_HK |
dc.contributor.author | Kung, AWC | en_HK |
dc.contributor.author | Lau, CP | en_HK |
dc.contributor.author | Tse, HF | en_HK |
dc.date.accessioned | 2010-09-06T07:19:45Z | - |
dc.date.available | 2010-09-06T07:19:45Z | - |
dc.date.issued | 2007 | en_HK |
dc.identifier.citation | Journal Of Clinical Endocrinology And Metabolism, 2007, v. 92 n. 5, p. 1736-1742 | en_HK |
dc.identifier.issn | 0021-972X | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/76299 | - |
dc.description.abstract | Context: Recent reports suggest an association between hyperthyroidism and pulmonary hypertension (PHT), although the potential mechanisms and clinical implications remain unclear. Objective: Our objective was to determine the prevalence of PHT related to hyperthyroidism and the associated hemodynamic changes and outcome. Methods and Results: We performed serial echocardiographic examinations in 75 consecutive patients with hyperthyroidism (43 ± 2 yr, 47 women) to estimate pulmonary artery systolic pressure (PASP), cardiac output (CO), total vascular resistance (TVR), and left ventricular (LV) filling pressure. Examinations were performed at baseline and 6 months after initiation of antithyroid treatment. Results were compared with 35 age- and sex-matched healthy controls. All hyperthyroid patients had normal LV systolic function, and 35 patients (47%) had PHT with PASP of at least 35 mm Hg. There were no significant differences in the clinical characteristics of hyperthyroid patients with or without PHT (all P > 0.05). Nonetheless, those with PHT had significantly higher CO, PASP, peak transmitral early diastolic flow velocity (E), and ratio of E to early diastolic mitral annular velocity (E′) compared with those without PHT and controls (all P < 0.05). Hyperthyroid patients with PHT also had significantly lower TVR than controls (P < 0.05). Among the 35 hyperthyroid patients with PHT, 25 (71%) had pulmonary arterial hypertension (PAH) with normal E/E′, and 10 (29%) had pulmonary venous hypertension (PVH) with elevated E/E′. Hyperthyroid patients with PAH had a significantly higher CO and a lower TVR compared with those with PVH. In contrast, hyperthyroid patients with PVH had lower E′ and a higher E/E′ ratio compared with those with PAH. These hemodynamic abnormalities and PHT were reversible in patients with PAH or PVH after restoration to a euthyroid state. Conclusion: In patients with hyperthyroidism and normal LV systolic function, up to 47% had PHT due to either PAH with increased CO (70%) or PVH with elevated LV filling pressure (30%). Most importantly, hyperthyroidism-related PHT was largely asymptomatic and reversible after restoration to a euthyroid state. Copyright © 2007 by The Endocrine Society. | en_HK |
dc.language | eng | en_HK |
dc.publisher | The Endocrine Society. The Journal's web site is located at http://jcem.endojournals.org | en_HK |
dc.relation.ispartof | Journal of Clinical Endocrinology and Metabolism | en_HK |
dc.rights | Journal of Clinical Endocrinology and Metabolism. Copyright © The Endocrine Society. | en_HK |
dc.subject.mesh | Adult | en_HK |
dc.subject.mesh | Antithyroid Agents - therapeutic use | en_HK |
dc.subject.mesh | Blood Pressure - physiology | en_HK |
dc.subject.mesh | Carbimazole - therapeutic use | en_HK |
dc.subject.mesh | Cardiac Output - physiology | en_HK |
dc.subject.mesh | Echocardiography | en_HK |
dc.subject.mesh | Echocardiography, Doppler | en_HK |
dc.subject.mesh | Female | en_HK |
dc.subject.mesh | Follow-Up Studies | en_HK |
dc.subject.mesh | Humans | en_HK |
dc.subject.mesh | Hypertension, Pulmonary - etiology - physiopathology - ultrasonography | en_HK |
dc.subject.mesh | Hyperthyroidism - complications - physiopathology - ultrasonography | en_HK |
dc.subject.mesh | Male | en_HK |
dc.subject.mesh | Middle Aged | en_HK |
dc.subject.mesh | Propylthiouracil - therapeutic use | en_HK |
dc.subject.mesh | Prospective Studies | en_HK |
dc.subject.mesh | Treatment Outcome | en_HK |
dc.subject.mesh | Vascular Resistance - physiology | en_HK |
dc.subject.mesh | Ventricular Function, Left - physiology | en_HK |
dc.title | Hemodynamic changes in hyperthyroidism-related pulmonary hypertension: A prospective echocardiographic study | en_HK |
dc.type | Article | en_HK |
dc.identifier.openurl | http://library.hku.hk:4550/resserv?sid=HKU:IR&issn=0021-972X&volume=92&spage=1736&epage=42&date=2007&atitle=Hemodynamic+changes+in+hyperthyroidism-related+pulmonary+hypertension:+a+prospective+echocardiographic+study | en_HK |
dc.identifier.email | Siu, CW:cwdsiu@hkucc.hku.hk | en_HK |
dc.identifier.email | Kung, AWC:awckung@hku.hk | en_HK |
dc.identifier.email | Tse, HF:hftse@hkucc.hku.hk | en_HK |
dc.identifier.authority | Siu, CW=rp00534 | en_HK |
dc.identifier.authority | Kung, AWC=rp00368 | en_HK |
dc.identifier.authority | Tse, HF=rp00428 | en_HK |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1210/jc.2006-1877 | en_HK |
dc.identifier.pmid | 17327384 | - |
dc.identifier.scopus | eid_2-s2.0-34249852339 | en_HK |
dc.identifier.hkuros | 142049 | en_HK |
dc.identifier.hkuros | 126521 | - |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-34249852339&selection=ref&src=s&origin=recordpage | en_HK |
dc.identifier.volume | 92 | en_HK |
dc.identifier.issue | 5 | en_HK |
dc.identifier.spage | 1736 | en_HK |
dc.identifier.epage | 1742 | en_HK |
dc.identifier.isi | WOS:000246221200029 | - |
dc.publisher.place | United States | en_HK |
dc.identifier.scopusauthorid | Siu, CW=7006550690 | en_HK |
dc.identifier.scopusauthorid | Zhang, XH=16425051500 | en_HK |
dc.identifier.scopusauthorid | Yung, C=15770437000 | en_HK |
dc.identifier.scopusauthorid | Kung, AWC=7102322339 | en_HK |
dc.identifier.scopusauthorid | Lau, CP=7401968501 | en_HK |
dc.identifier.scopusauthorid | Tse, HF=7006070805 | en_HK |
dc.identifier.issnl | 0021-972X | - |